September 17, 2019 — Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically reduce episodes of rapid, abnormal heartbeats for more than two years, according to new research from the ENCORE-VT trial. This could offer hope to patients who have exhausted other treatment options. Findings were presented at the 61st annual meeting of the American Society for Radiation Oncology (ASTRO), Sept.

At the 2019 American Society for Radiation Oncology (ASTRO) Annual Meeting, running Sept. 15-18 in Chicago, Sun Nuclear Corp. will present novel advancements in radiation oncology quality management.

At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, being held Sept. 15-18 in Chicago, Varian announced Ethos therapy, an artificial intelligence (AI)-driven holistic solution designed to increase the capability, flexibility and efficiency of radiotherapy. This new solution is designed to deliver an entire adaptive treatment in a typical 15-minute timeslot, from patient setup through treatment delivery.

Secondary analysis of a recent clinical trial that changed the standard of care for men with recurring prostate cancer finds long-term hormone therapy does more harm than good for many men. The researchers say this calls for rethinking treatment guidelines based on a patient’s post-operative prostate-specific antigen (PSA) level. Findings were presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 15-18 in Chicago.

Siemens Healthineers debuted two computed tomography (CT) systems dedicated to radiation therapy (RT) planning at the 2019 annual meeting of the American Society for Radiation Oncology (ASTRO), Sept. 15-18 in Chicago. The new introductions include the Somatom go.Sim and the Somatom go.Open Pro, both of which are pending U.S. Food and Drug Administration (FDA) 510(k) clearance and are not yet commercially available in the United States.

Radiation dose management is central to child patient safety. Medical imaging plays an increasing role in the accurate diagnosis and treatment of numerous medical conditions. The speed, accuracy and noninvasiveness of medical imaging have also contributed to a sharp increase in the number of imaging procedures

Isoray Inc. announced it will spotlight the growing cancer treatment applications of Cesium-131 brachytherapy at the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago.

The Akesis Galaxy, a gamma stereotactic radiosurgery system (SRS) with continuous 360-degree rotational technology, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), making the system available to clinicians in the United States.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now